Bryan Dickinson

Bioorthogonal masked acylating agents for proximity-dependent RNA labelling.
Bioorthogonal masked acylating agents for proximity-dependent RNA labelling. Nat Chem. 2024 Apr 09.
PMID: 38594368

Mechanisms and functions of protein S-acylation.
Mechanisms and functions of protein S-acylation. Nat Rev Mol Cell Biol. 2024 Feb 14.
PMID: 38355760

Fear extinction is regulated by the activity of long noncoding RNAs at the synapse.
Fear extinction is regulated by the activity of long noncoding RNAs at the synapse. Nat Commun. 2023 Nov 22; 14(1):7616.
PMID: 37993455

RNA-based translation activators for targeted gene upregulation.
RNA-based translation activators for targeted gene upregulation. Nat Commun. 2023 10 26; 14(1):6827.
PMID: 37884512

Regulation of ERK2 activity by dynamic S-acylation.
Regulation of ERK2 activity by dynamic S-acylation. Cell Rep. 2023 09 26; 42(9):113135.
PMID: 37715953

Synapse-Enriched m6A-Modified Malat1 Interacts with the Novel m6A Reader, DPYSL2, and Is Required for Fear-Extinction Memory.
Synapse-Enriched m6A-Modified Malat1 Interacts with the Novel m6A Reader, DPYSL2, and Is Required for Fear-Extinction Memory. J Neurosci. 2023 10 25; 43(43):7084-7100.
PMID: 37669863

Nm-Mut-seq: a base-resolution quantitative method for mapping transcriptome-wide 2'-O-methylation.
Nm-Mut-seq: a base-resolution quantitative method for mapping transcriptome-wide 2'-O-methylation. Cell Res. 2023 09; 33(9):727-730.
PMID: 37316584

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies. Nat Commun. 2023 05 26; 14(1):3035.
PMID: 37236967

Innate Conformational Dynamics Drive Binding Specificity in Anti-Apoptotic Proteins Mcl-1 and Bcl-2.
Innate Conformational Dynamics Drive Binding Specificity in Anti-Apoptotic Proteins Mcl-1 and Bcl-2. Biochemistry. 2023 06 06; 62(11):1619-1630.
PMID: 37192192

Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy. Pharmaceuticals (Basel). 2023 May 07; 16(5).
PMID: 37242495

View All Publications